Want to see MED full AI Analyst Report?
MED Stock Chart & Stats
$10.97
-$0.62(-3.78%)
At close: 4:00 PM EST
$10.97
-$0.62(-3.78%)
Day’s Range― - ―
52-Week Range$9.22 - $15.37
Previous CloseN/A
Volume160.90K
Average Volume (3M)183.09K
Market Cap
$114.08M
Enterprise Value-$40.69
Total Cash (Recent Filing)$168.95M
Total Debt (Recent Filing)$16.10M
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Aug 03, 2026EPS Estimate
-0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.82
Shares Outstanding11,119,115
10 Day Avg. Volume175,854
30 Day Avg. Volume183,095
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.59
Price to Sales (P/S)0.30
P/FCF Ratio93.90
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.85
Revenue Forecast (FY)$279.70M
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet And LiquidityA large cash position and negligible leverage provide multi-quarter runway to fund the strategic repositioning, absorb near-term losses, and invest in the Trilivy launch. This financial flexibility reduces refinancing risk and supports durable execution of long-term recovery plans.
Strong Product-level Gross MarginsHigh gross margins on packaged nutrition imply durable product economics and pricing power. When volumes recover, these margins can flow to the bottom line faster than low-margin businesses, enabling significant operating leverage versus competitors reliant on lower-margin offerings.
Improving Coach Productivity And Referral MomentumRising revenue per coach and stronger referral acquisition indicate higher monetization of the core channel. Sustained productivity gains and referral-driven client growth are structurally positive for unit economics and scalable customer acquisition if the coach base stabilizes.
Bears Say
Material Revenue Decline And Coach AttritionA sharp multi-quarter revenue drop and steep coach losses strike at the heart of Medifast’s coach-led DTC model. Rebuilding a dispersed independent coach network is a multi-quarter structural challenge that constrains sustainable top-line recovery and recurring revenue.
Negative Profitability And Weakening Cash ConversionThe shift to negative free cash flow and persistent net losses reduces financial flexibility over time. Even with cash reserves, prolonged cash burn forces either deeper cost cuts or slower investment in growth, raising the bar for a durable return to profitable operations.
Market Disruption And Execution Dependence On New ProductStructural disruption from GLP-1 therapies has altered consumer behavior and eroded the coach base. Management’s recovery plan hinges on the Trilivy product rollout; reliance on a single launch creates material execution risk and makes sustainable recovery contingent on timely adoption.
Medifast News
MED FAQ
What was Medifast’s price range in the past 12 months?
Medifast lowest stock price was $9.22 and its highest was $15.37 in the past 12 months.
What is Medifast’s market cap?
Medifast’s market cap is $114.08M.
When is Medifast’s upcoming earnings report date?
Medifast’s upcoming earnings report date is Aug 03, 2026 which is in 13 days.
How were Medifast’s earnings last quarter?
Medifast released its earnings results on May 04, 2026. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.52 by $0.33.
Is Medifast overvalued?
According to Wall Street analysts Medifast’s price is currently Overvalued.
Does Medifast pay dividends?
Medifast pays a Quarterly dividend of $1.65 which represents an annual dividend yield of N/A. See more information on Medifast dividends here
What is Medifast’s EPS estimate?
Medifast’s EPS estimate is -0.65.
How many shares outstanding does Medifast have?
Medifast has 11,119,115 shares outstanding.
What happened to Medifast’s price movement after its last earnings report?
Medifast reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.52. Following the earnings report the stock price went up 22.484%.
Which hedge fund is a major shareholder of Medifast?
Currently, no hedge funds are holding shares in MED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medifast Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MED Sentiment 67%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 294.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $63.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.03%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-9.99%
Trailing 12-Months
Company Description
Medifast
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
Technical Analysis
Ownership Overview
5.36% Insiders
14.59% Mutual Funds
0.40% Other Institutional Investors
67.47% Public Companies and
Individual Investors